Capricor Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.75 M | $26.62 M | 100.00% | 5.29% |
VANGUARD GROUP INC | 11/13/2024 | 1.58 M | $23.98 M | 1.78% | 4.76% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 812,900 | $12.36 M | 522.91% | 2.46% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 638,189 | $9.71 M | -0.53% | 1.93% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 576,300 | $8.77 M | 88.52% | 1.74% |
STATE STREET CORP | 11/14/2024 | 512,313 | $7.79 M | 27.75% | 1.55% |
SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2024 | 337,347 | $5.13 M | 100.00% | 1.02% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 300,000 | $4.56 M | 100.00% | 0.91% |
ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 285,000 | $4.33 M | 100.00% | 0.86% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 261,600 | $3.98 M | 685.59% | 0.79% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 250,204 | $3.81 M | 100.00% | 0.76% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 240,750 | $3.66 M | 48.34% | 0.73% |
PFM HEALTH SCIENCES, LP | 11/14/2024 | 152,779 | $2.32 M | 100.00% | 0.46% |
CITADEL ADVISORS LLC | 11/14/2024 | 151,900 | $2.31 M | 313.90% | 0.46% |
LMR PARTNERS LLP | 11/07/2024 | 151,800 | $2.31 M | 100.00% | 0.46% |
MORGAN STANLEY | 11/14/2024 | 131,516 | $2.00 M | 66.07% | 0.40% |
GHOST TREE CAPITAL, LLC | 11/14/2024 | 125,000 | $1.90 M | 100.00% | 0.38% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 123,412 | $1.88 M | 204.74% | 0.37% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 121,800 | $1.85 M | 1,060.00% | 0.37% |
JANE STREET GROUP, LLC | 11/15/2024 | 99,126 | $1.51 M | 441.20% | 0.30% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 94,757 | $1.44 M | -80.24% | 0.29% |
STEMPOINT CAPITAL LP | 11/13/2024 | 93,638 | $1.42 M | 100.00% | 0.28% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 90,365 | $1.37 M | 100.00% | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 87,750 | $1.33 M | 100.00% | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 87,700 | $1.33 M | 100.00% | 0.27% |
CITADEL ADVISORS LLC | 11/14/2024 | 83,900 | $1.28 M | 126.15% | 0.25% |
UBS OCONNOR LLC | 11/14/2024 | 82,900 | $1.26 M | 100.00% | 0.25% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 78,264 | $1.19 M | -5.36% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 73,468 | $1.12 M | 0.00% | 0.22% |
EAM INVESTORS, LLC | 11/13/2024 | 69,925 | $1.06 M | 100.00% | 0.21% |
OPPENHEIMER & CO INC | 11/05/2024 | 68,408 | $1.04 M | 25.18% | 0.21% |
JANE STREET GROUP, LLC | 11/15/2024 | 66,200 | $1.01 M | 100.00% | 0.20% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 63,389 | $964,149 | -20.55% | 0.19% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 61,698 | $938,427 | 100.00% | 0.19% |
JPMORGAN CHASE & CO | 11/08/2024 | 56,199 | $854,786 | 419.50% | 0.17% |
GTS SECURITIES LLC | 11/13/2024 | 50,600 | $769,626 | 100.00% | 0.15% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 44,132 | $671,248 | -1.81% | 0.13% |
GTS SECURITIES LLC | 11/13/2024 | 40,600 | $617,526 | 100.00% | 0.12% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 39,616 | $602,559 | 100.00% | 0.12% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 36,793 | $559,622 | 53.87% | 0.11% |
BARCLAYS PLC | 11/19/2024 | 36,296 | $552,000 | 106.56% | 0.11% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 34,320 | $522,007 | 0.00% | 0.10% |
RHUMBLINE ADVISERS | 11/12/2024 | 31,914 | $485,402 | 3.33% | 0.10% |
COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 31,280 | $476,000 | 4.27% | 0.09% |
VIRTU FINANCIAL LLC | 11/20/2024 | 30,112 | $458,000 | 100.00% | 0.09% |
FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 26,241 | $399,126 | 100.00% | 0.08% |
FMR LLC | 11/13/2024 | 24,344 | $370,272 | 100.00% | 0.07% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 24,307 | $369,709 | 100.00% | 0.07% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 24,100 | $366,561 | 100.00% | 0.07% |
MYDA ADVISORS LLC | 11/13/2024 | 24,000 | $365,040 | 100.00% | 0.07% |
Capricor Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 89 institutional investors and hedge funds held shares of Capricor Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 1.75 M
VANGUARD GROUP INC: 1.58 M
GEODE CAPITAL MANAGEMENT, LLC: 638,189
STATE STREET CORP: 512,313
SUPERSTRING CAPITAL MANAGEMENT LP: 337,347
Ikarian Capital, LLC: 300,000
25.29% of Capricor Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 9.69 M shares in the last 24 months. This purchase volume represents approximately $137.14 M in transactions.